Similar articles for PMID: 19515405

Year	Number of Results
2000	1
2001	2
2002	1
2003	2
2004	1
2005	5
2006	6
2007	7
2008	8
2009	10
2010	9
2011	6
2012	17
2013	13
2014	23
2015	15
2016	25
2017	19
2018	22
2019	25
2020	36
2021	16
2022	20
2023	9
2024	0

1

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O'Malley DM, Cohn DE. Backes FJ, et al. Gynecol Oncol. 2009 Sep;114(3):486-90. doi: 10.1016/j.ygyno.2009.05.026. Epub 2009 Jun 10. Gynecol Oncol. 2009. PMID: 19515405

2

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA. Garg K, et al. Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866. Am J Surg Pathol. 2009. PMID: 19898223

3

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM. Rabban JT, et al. Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177. Am J Surg Pathol. 2014. PMID: 24503759

4

Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.

Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Aysal A, et al. Am J Surg Pathol. 2012 Feb;36(2):163-72. doi: 10.1097/PAS.0b013e31823bc434. Am J Surg Pathol. 2012. PMID: 22189970

5

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M. Nelson GS, et al. Gynecol Oncol. 2013 Nov;131(2):309-14. doi: 10.1016/j.ygyno.2013.08.003. Epub 2013 Aug 11. Gynecol Oncol. 2013. PMID: 23938375

6

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.

Shih KK, Garg K, Levine DA, Kauff ND, Abu-Rustum NR, Soslow RA, Barakat RR. Shih KK, et al. Gynecol Oncol. 2011 Oct;123(1):88-94. doi: 10.1016/j.ygyno.2011.06.005. Epub 2011 Jul 13. Gynecol Oncol. 2011. PMID: 21742371

7

Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.

Long Q, Peng Y, Tang Z, Wu C. Long Q, et al. Int J Clin Exp Pathol. 2014 Sep 15;7(10):7297-303. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400828 Free PMC article.

8

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Mills AM, et al. Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321. Am J Surg Pathol. 2014. PMID: 25229768 Free PMC article.

9

Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.

Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A. Ruiz I, et al. Gynecol Oncol. 2014 Jul;134(1):20-3. doi: 10.1016/j.ygyno.2014.04.053. Epub 2014 May 9. Gynecol Oncol. 2014. PMID: 24814467

10

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.

Moline J, Mahdi H, Yang B, Biscotti C, Roma AA, Heald B, Rose PG, Michener C, Eng C. Moline J, et al. Gynecol Oncol. 2013 Jul;130(1):121-6. doi: 10.1016/j.ygyno.2013.04.022. Epub 2013 Apr 20. Gynecol Oncol. 2013. PMID: 23612316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

268 results

Results by year